In another study, costunolide significantly reduced VEGF secretion and decreased VEGF mRNA levels in human gastric cancer (AGS), colon cancer (Caco-2), and liver cancer (HepG2/C3A) cells. Here, VEGFA is linked to colonic neoplasm.